GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Lifecare ASA (OSL:LIFES) » Definitions » LT-Debt-to-Total-Asset

Lifecare ASA (OSL:LIFES) LT-Debt-to-Total-Asset : 0.07 (As of Dec. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Lifecare ASA LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Lifecare ASA's long-term debt to total assests ratio for the quarter that ended in Dec. 2024 was 0.07.

Lifecare ASA's long-term debt to total assets ratio increased from Dec. 2023 (0.06) to Dec. 2024 (0.07). It may suggest that Lifecare ASA is progressively becoming more dependent on debt to grow their business.


Lifecare ASA LT-Debt-to-Total-Asset Historical Data

The historical data trend for Lifecare ASA's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lifecare ASA LT-Debt-to-Total-Asset Chart

Lifecare ASA Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
LT-Debt-to-Total-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 0.08 0.10 0.06 0.07

Lifecare ASA Quarterly Data
Dec15 Dec16 Dec17 Jun18 Dec18 Jun19 Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
LT-Debt-to-Total-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.06 0.06 0.07 0.06 0.07

Lifecare ASA LT-Debt-to-Total-Asset Calculation

Lifecare ASA's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2024 is calculated as

LT Debt to Total Assets (A: Dec. 2024 )=Long-Term Debt & Capital Lease Obligation (A: Dec. 2024 )/Total Assets (A: Dec. 2024 )
=8.274/112.593
=0.07

Lifecare ASA's Long-Term Debt to Total Asset Ratio for the quarter that ended in Dec. 2024 is calculated as

LT Debt to Total Assets (Q: Dec. 2024 )=Long-Term Debt & Capital Lease Obligation (Q: Dec. 2024 )/Total Assets (Q: Dec. 2024 )
=8.274/112.593
=0.07

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Lifecare ASA  (OSL:LIFES) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.


Lifecare ASA LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Lifecare ASA's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Lifecare ASA Business Description

Traded in Other Exchanges
Address
Ytrebygdsvegen 215, Blomsterdalen, Bergen, NOR, 5258
Lifecare ASA focuses on the research, development, and commercialization of sensor technology for continuous monitoring of body analytes. Lifecare develops and licenses nanotechnology for medical use to facilitate the production and sale of medical devices. Its miniaturized sensor technology measures changes by reading osmotic pressure variations in a small chamber, and can, e.g., measure glucose and lactate levels by applying different chemical compositions. The company operates as a single segment focused on research and development (R&D) of its osmotic pressure sensor and related components.

Lifecare ASA Headlines

No Headlines